Shiny K. Kajal/LinkedIn
Mar 24, 2026, 02:55
Shiny K Kajal: FFP as a Targeted Coagulation Therapy
Shiny K. Kajal, Senior Resident at Adesh University, shared a post on LinkedIn:
”Post 27- FFP is not just ‘something to hang.’
It’s not a fluid.
It’s not a reflex.
It’s not routine.
It is targeted coagulation therapy.
If there’s no active bleeding or significant coagulopathy,
ask yourself – what exactly are you treating?
Because every unit carries risk:
TRALI. TACO. Allergic reactions. Infection.
More plasma ≠ better outcomes.
Correction ≠ clinical benefit.
Transfuse with purpose.
Dose appropriately.
Treat the patient – not the comfort of doing something.”
Shiny K. Kajal/LinkedIn
Stay updated with Hemostasis Today.
-
Sep 22, 2026, 09:18Shamee Shastry: How Transfusion Medicine Research Is Evolving in India
-
Sep 22, 2026, 09:11Tarique Shahzad Chachar: Why Warfarin Remains the Gold Standard for Mechanical Heart Valves
-
Sep 22, 2026, 09:04Bianca Rocca: Thromboinflammatory Injury in Ischemic Limb Necrosis During Severe Shock
-
Sep 22, 2026, 09:01Ash Paul: Comparing Left Atrial Appendage Occlusion and Oral Anticoagulation
-
Sep 22, 2026, 08:50Emily Horner: Lipoprotein(a) Links Oxidized Phospholipids to Platelet Hyperactivity
-
Sep 22, 2026, 08:42Sally Mandour: Bone Marrow Needle Gauge Explained
-
Sep 22, 2026, 08:39Alessandro Sionis: Navigating Anticoagulation in Mechanical Circulatory Support
-
Sep 22, 2026, 08:28Raghavendra Rao: The Latest Research on Varicose Veins
-
Sep 22, 2026, 08:23Aravind Palraj: Three Essential Tests in Antiphospholipid Syndrome